Nuveen
AKTX icon

Nuveen’s Akari Therapeutics AKTX Stock Holding History

Nuveen’s Portfolio AKTX Stock Details AKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$836 Buy
+86
New +$835 ﹤0.01% 4939

Other funds holding AKTX

Occidental Asset Management
Occidental Asset Management Burlingame, California $1.16B AUM 26.15% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Nuveen's AKTX Position: Q3 2026 in Review

Nuveen opened a new position in Akari Therapeutics (AKTX) in Q3 2026: 86 shares worth $836. The stake represents ﹤0.01% of the portfolio and ranks #4939 among its holdings.

6 funds tracked by Wall St. Rank hold AKTX as of Q3 2026.

  • Nuveen held 86 shares of Akari Therapeutics worth $836 as of Q3 2026.
  • Akari Therapeutics was a new Nuveen position in Q3 2026.
  • Akari Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4939 holding.
  • 6 funds tracked by Wall St. Rank held Akari Therapeutics as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.